Abstract
Background
Prevalence of allergic diseases in infants is approximately 10% reaching 20 to 30% in those with an allergic first-degree relative. Prebiotics are selectively fermented food ingredients that allow specific changes in composition/activity of the gastrointestinal microflora. They modulate immune responses and their supplementation has been proposed as an intervention to prevent allergies.
Objective
To assess in pregnant women, breastfeeding mothers, and infants (populations) the effect of supplementing prebiotics (intervention) versus no prebiotics (comparison) on the development of allergic diseases and to inform the World Allergy Organization guidelines.
Methods
We performed a systematic review of studies assessing the effects of prebiotic supplementation with an intention to prevent the development of allergies.
Results
Of 446 unique records published until November 2016 in Cochrane, MEDLINE, and Embase, 22 studies fulfilled a priori specified criteria. We did not find any studies of prebiotics given to pregnant women or breastfeeding mothers. Prebiotic supplementation in infants, compared to placebo, had the following effects: risk of developing eczema (RR: 0.68, 95% CI: 0.40 to 1.15), wheezing/asthma (RR, 0.37; 95% CI: 0.17 to 0.80), and food allergy (RR: 0.28, 95% CI: 0.08 to 1.00). There was no evidence of an increased risk of any adverse effects (RR: 1.01, 95% CI: 0.92 to 1.10). Prebiotic supplementation had little influence growth rate (MD: 0.92 g/day faster with prebiotics, 95% CI: 0 to 1.84), and the final infant weight (MD: 0.10 kg higher with prebiotics, (95% CI: -0.09 to 0.29). The certainty of these estimates is very low due to risk of bias and imprecision of the results.
Conclusions
Currently available evidence on prebiotic supplementation to reduce the risk of developing allergies is very uncertain.
This article is protected by copyright. All rights reserved.
http://ift.tt/2zqoGc1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου